Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03970382
Title A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors PACT Pharma, Inc.
Indications

prostate cancer

ovarian cancer

breast cancer

colorectal cancer

melanoma

transitional cell carcinoma

Therapies

NeoTCR-P1 T-cells + Nivolumab

NeoTCR-P1 T-cells

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.